Steven C. Quay

All filings by Steven C. Quay on record concern Atossa Therapeutics, Inc., in the capacity of chief executive. Over a trading history stretching from 19 January 2016 to 27 March 2026, the count stands at 5 filings.

On the market, this insider has only ever bought: 2 purchases, €8,725 in total. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 share grants.

On 31 March 2026 came the latest disclosure, a share grant in Atossa Therapeutics, Inc. The last purchase on record was published on 22 May 2025, which is 514 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.